Intracranial pressure is monitored and, if elevated, is treated with drugs such as mannitol and barbiturates placing the patient on a ventilator so that hyperventilation can be used.
OHS patients experience low oxygen saturation levels during the day and the night because of shallow breathing (hyperventilation) often related to obesity.
Hyperventilation hypoxia CPAP can help a patient lose the weight they need to lose to decrease their risks for recurring OHS.
However, if a patient has a seizure disorder, a seizure may be triggered by the flashing lights or hyperventilation.
Hyperventilation hypoxia CPAP refers to a treatment for obesity hypoventilation syndrome (OHS).